Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells

Metabolism: Clinical and Experimental

Volumn 46, Issue 8, 1997, Pages 918-925

  Studer, R K ^b   Craven, P A ^b   DeRubertis, F R ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANGIOTENSIN; ANTIOXIDANT; DIACYLGLYCEROL; GLUCOSE; PROTEIN KINASE C; TAURINE; THROMBOXANE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GLOMERULOSCLEROSIS; MESANGIUM CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RAT; REGULATORY MECHANISM;

EID: 0030838053     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90080-9     Document Type: Article

References (38)

1. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988
2. Steffes MW, Bious RW, Sutherland DM, et al: Cell and matrix components of glomerular mesangium in type I diabetes. Diabetes 41:679-684, 1992
3. DeRubertis FR, Craven PA: Activation of PKC in glomerular cells in diabetes. Diabetes 43:1-8, 1994
4. Ayo SH, Radnik R, Garoni JA, et al: High glucose increases diacylglycerol mass and activates PKC in mesangial cell cultures. Am J Physiol 261:F571-F577, 1991
5. Studer RK, Craven PA, DeRubertis FR: Role for PKC in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes 42:118-126, 1993
6. Studer RK, Craven PA, DeRubertis FR: Thromboxane stimulation of mesangial cell fibronectin synthesis is signalled by PKC and modulated by cGMP. Kidney Int 46:1074-1082, 1994
7. Studer RK, Craven PA, DeRubertis FR: Low-density lipoprotein stimulation of mesangial cell fibronectin synthesis: Role of PKC and transforming growth factor-β. J Lab Clin Med 125:86-95, 1995
8. Kagami S, Border WA, Mille DE, et al: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
9. Harris RC, Aka Y, Yasuda T, et al: The role of physical forces in alterations of mesangial cell function. Kidney Int 45:517-521, 1994
10. Negrete H, Studer RK, Craven PA, et al: Role for transforming growth factor-β in thromboxane-induced increases in mesangial cell fibronectin synthesis. Diabetes 44:335-339, 1995
11. Studer RK, Negrete H, Craven PA, et al: Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGFβ bioactivity in mesangial cells. Kidney Int 48:422-430, 1995
12. Craven PA, Studer RK, DeRubertis FR: S-nitroso-n-acetylpenicil-lamine (SNAP) suppresses increases in PKC, transforming growth factor-β, and collagen synthesis induced by HG in mesangial cells. J Am Soc Nephrol 6:1040, 1995 (abstr)
13. Border WA, Ruoslahti E: Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 90:1-7, 1992
14. Sharma K, Ziyadeh FN: The emerging role of transforming growth factor-β in kidney disease. Am J Physiol 266:F829-F842, 1994
15. Ziyadeh FN, Sharma K, Erickson M, et al: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of transforming growth factor-β1. J Clin Invest 93:536-542, 1994
16. Kass GEN, Duddy SK, Orrenius S: Activation of hepatocyte PKC by redox-cycling quinones. Biochem J 260:499-507, 1989
17. Gopalakrishna R, Anderson WB: Reversible oxidative activation and inactivation of PKC by the mitogen/tumor promoter periodate. Arch Biochem Biophys 285:382-387, 1991
18. Palumbo EJ, Sweatt JD, Chen S-J, et al: Oxidation-induced persistent activation of PKC in hippocampal homogenates. Biochem Biophys Res Commun 187:1439-1445, 1992
19. Kunisaki M, Bursell S-E, Umeda R, et al: Normalization of diacylglycerol-PKC activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 43:1372-1377, 1994
20. Kunisaki M, Bursell S-E, Clermone AC, et al: Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-PKC pathway. Am J Physiol 269:E239-E246, 1995
21. Koya D, Ishii H, King GL: Prevention of glomerular hyperfiltration in diabetic rats through the inhibition of DAG-PKC signaling by vitamin E. JASN 6:1042, 1995
22. Puri PL, Avantaggiati ML, Burgio VL, et al: Reactive oxygen intermediates mediate angiotensin II-induced c-Jun-c-Fos heterodimer DNA binding activity and proliferative hypertrophic responses in myogenic cells. J Biol Chem 270:22129-22134, 1995
23. Trachtman H: Vitamin E prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Microvasc Res 47:232-239, 1994
24. Trachtman H, Futterweit S, Prenner J, et al: Antioxidants reverse the antiproliferative effect of HG and advanced glycosylation end products in cultured rat mesangial cells. Biochem Biophys Res Commun 199:346-352, 1994
25. Craven PA, Studer RK, Felder J, et al: Nitric oxide inhibition of transforming growth factor âand collagen synthesis in mesangial cells. Diabetes (in press)
26. Peterkofsky B, Diegelmann R: Use of a mixture of proteinase free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 10:988-994, 1971
27. Chen Q, Olashaw N, Wu J: Participation of reactive oxygen species in the phosphatidic acid-stimulated mitogen-activated protein kinase activation pathway. J Biol Chem 270:28499-28502, 1995
28. Huxtable RJ: Physiological actions of taurine. Physiol Rev 72:101-163, 1992
29. Kochs G, Jummel R, Meyer D, et al: Activation and substrate specificity of the human PKC and isoenzymes. Eur J Biochem 216:597-606, 1993
30. Boscoboinik D, Szewczyk A, Hensey C, et al: Inhibition of cell proliferation by α-tocopherol. J Biol Chem 266:6188-6194, 1991
31. Stauble B, Boscoboinik D, Tasinato A, et al: Modulation of activator protein-1 (AP-1) transcription factor and PKC by hydrogen peroxide and D-α-tocopherol in VSMC. Eur J Biochem 226:393-402, 1994
32. Chatelain E, Boscoboinik DO, Baroli G-M, et al: Inhibition of smooth muscle proliferation and PKC activity by tocopherols and tocotrienols. Biochim Biophys Acta 1176:83-89, 1993
33. Tran K, Prouiz PR, Chan AC: Vitamin E suppresses diacylglycerol (DAG) level in thrombin-stimulated endothelial cells through an increase of DG kinase activity. Biochim Biophys Acta 1212:193-202, 1994
34. Lee IK, Koya D, Ishii H, et al: Vitamin E (α-tocopherol) prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in VSMC by an increase of DAG kinase activity. Diabetes 45:64A, 1996 (abstr)
35. Koya D, Lee IK, Ishi H, et al: Vitamin E normalized glomerular hyperfiltration and PKC activation by increasing diacylglycerol kinase in diabetic rats. Diabetes 45:205A, 1996 (abstr)
36. Trachtman H, Futterweit S, Maesake J, et al: Taurine ameliorates chronic streptozotocin-induced diabetic nephropathy in rats. Am J Physiol 269:F429-F438, 1995
37. Trachtman H, Schwab N: Administration of vitamin E (α-tocopherol) attenuates chronic puromycin aminonucleoside nephropathy (PAN). JASN 4:785, 1993
38. Bowry V, Ingold KU, Stocker R: Vitamin E in human low density lipoprotein; when and how this antioxidant becomes a prooxidant. Biochem J 288:341-344, 1992